Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DOUGLAS A GOLDBERG

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1992731780
CMS profile
271702
Location
ROSLYN HEIGHTS, NY

General Payments · PY2018–2024

$2,776.16

  • Reported across 192 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$485.36

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $485.36 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $158.53 4
PY2019 $206.33 14
PY2020 $37.84 2
PY2021 $445.00 27
PY2022 $737.87 59
PY2023 $705.23 52
PY2024 $485.36 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $30.63 01/10/2024 Food and Beverage Undisputed 01/23/2026 1078905209 CMS
Actelion Pharmaceuticals US, Inc. $26.69 09/20/2024 Food and Beverage Undisputed 01/23/2026 1078905207 CMS
Amgen Inc. $13.10 01/26/2024 Food and Beverage Undisputed 01/23/2026 1111585493 CMS
Amgen Inc. $14.93 05/15/2024 Food and Beverage Undisputed 01/23/2026 1111585495 CMS
Amgen Inc. $13.66 11/19/2024 Food and Beverage Undisputed 01/23/2026 1111585497 CMS
Amgen Inc. $13.68 12/20/2024 Food and Beverage Undisputed 01/23/2026 1111585499 CMS
E.R. Squibb & Sons, L.L.C. $24.54 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101397907 CMS
GENZYME CORPORATION $44.77 06/21/2024 Food and Beverage Undisputed 01/23/2026 1139875118 CMS
Janssen Pharmaceuticals, Inc $5.16 01/30/2024 Food and Beverage Undisputed 01/23/2026 1078118354 CMS
Janssen Pharmaceuticals, Inc $15.78 02/27/2024 Food and Beverage Undisputed 01/23/2026 1078118352 CMS
Janssen Pharmaceuticals, Inc $16.55 05/07/2024 Food and Beverage Undisputed 01/23/2026 1078118362 CMS
Janssen Pharmaceuticals, Inc $14.35 06/18/2024 Food and Beverage Undisputed 01/23/2026 1078118360 CMS
Janssen Pharmaceuticals, Inc $12.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 1078118356 CMS
Janssen Pharmaceuticals, Inc $16.11 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078118358 CMS
Novartis Pharmaceuticals Corporation $2.06 01/12/2024 Food and Beverage Undisputed 01/23/2026 1086908223 CMS
Novartis Pharmaceuticals Corporation $16.17 01/23/2024 Food and Beverage Undisputed 01/23/2026 1086908213 CMS
Novartis Pharmaceuticals Corporation $1.95 02/02/2024 Food and Beverage Undisputed 01/23/2026 1086908215 CMS
Novartis Pharmaceuticals Corporation $13.41 02/21/2024 Food and Beverage Undisputed 01/23/2026 1086908229 CMS
Novartis Pharmaceuticals Corporation $7.66 03/08/2024 Food and Beverage Undisputed 01/23/2026 1086908231 CMS
Novartis Pharmaceuticals Corporation $6.48 04/02/2024 Food and Beverage Undisputed 01/23/2026 1086908219 CMS
Novartis Pharmaceuticals Corporation $10.13 04/02/2024 Food and Beverage Undisputed 01/23/2026 1086908221 CMS
Novartis Pharmaceuticals Corporation $10.17 05/02/2024 Food and Beverage Undisputed 01/23/2026 1086908241 CMS
Novartis Pharmaceuticals Corporation $11.26 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086908243 CMS
Novartis Pharmaceuticals Corporation $6.18 06/21/2024 Food and Beverage Undisputed 01/23/2026 1086908257 CMS
Novartis Pharmaceuticals Corporation $1.88 06/21/2024 Food and Beverage Undisputed 01/23/2026 1086908259 CMS
Novartis Pharmaceuticals Corporation $13.24 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086908249 CMS
Novartis Pharmaceuticals Corporation $20.81 07/09/2024 Food and Beverage Undisputed 01/23/2026 1086908255 CMS
Novartis Pharmaceuticals Corporation $10.94 07/26/2024 Food and Beverage Undisputed 01/23/2026 1086908273 CMS
Novartis Pharmaceuticals Corporation $14.11 09/03/2024 Food and Beverage Undisputed 01/23/2026 1086908277 CMS
Novartis Pharmaceuticals Corporation $17.29 10/01/2024 Food and Beverage Undisputed 01/23/2026 1086908285 CMS
Novartis Pharmaceuticals Corporation $6.36 10/18/2024 Food and Beverage Undisputed 01/23/2026 1086908289 CMS
Novartis Pharmaceuticals Corporation $13.54 11/06/2024 Food and Beverage Undisputed 01/23/2026 1086908287 CMS
Novo Nordisk Inc $18.04 05/20/2024 Food and Beverage Undisputed 01/23/2026 1096993326 CMS
PFIZER INC. $21.62 01/18/2024 Food and Beverage Undisputed 01/23/2026 1130944037 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.